Cite

HARVARD Citation

    Basnet, S. et al. (n.d.). 52P MUC1 targeted immunotherapy with an oncolytic adenovirus coding for a bispecific T cell engager. Immuno-oncology technology. p. . [Online]. 
  
Back to record